Sheng-Jiang Powder Alleviates Th17/Treg Immune Imbalance of Experimental Autoimmune Encephalomyelitis by Regulating the Fatty Acids Metabolism
Drug Design, Development and Therapy · 2025-06 · Volume 19 · 4755-4776
DOI: 10.2147/dddt.s510620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-06. Verfasst von Lulu Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Th17 Cells, Drugs, Chinese Herbal, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
- The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
- Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
- Doctoral Candidates with the Same Academic Level of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
Zitieren
APA
Wu, L., Xu, H., Xia, H., Peng, L., Qin, L., Gong, Q., Zhao, M., Wu, Z., Zhao, Y., & Zheng, Z. (2025). Sheng-Jiang Powder Alleviates Th17/Treg Immune Imbalance of Experimental Autoimmune Encephalomyelitis by Regulating the Fatty Acids Metabolism. Drug Design, Development and Therapy, Volume 19, 4755-4776. https://doi.org/10.2147/dddt.s510620
Vancouver
Wu L, Xu H, Xia H, Peng L, Qin L, Gong Q, et al. Sheng-Jiang Powder Alleviates Th17/Treg Immune Imbalance of Experimental Autoimmune Encephalomyelitis by Regulating the Fatty Acids Metabolism. Drug Design, Development and Therapy. 2025;Volume 19:4755-4776. doi:10.2147/dddt.s510620
BibTeX
@article{Wu2025,
author = {Wu, Lulu and Xu, Haoyou and Xia, Hui and Peng, Lilin and Qin, Lulu and Gong, Qian and Zhao, Min and Wu, Zhibing and Zhao, Yuanqi and Zheng, Zequan},
title = {Sheng-Jiang Powder Alleviates Th17/Treg Immune Imbalance of Experimental Autoimmune Encephalomyelitis by Regulating the Fatty Acids Metabolism},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {4755--4776},
doi = {10.2147/dddt.s510620}
}
EUVIMED